|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1811 - 0.1958|
|52 Week Range||0.0110 - 0.5500|
|Beta (5Y Monthly)||4.30|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Datametrex AI Limited ( CVE:DM ) shareholders have seen the share price descend 14% over the month. But that doesn't...
Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) ("Datametrex" or the "Company") announces that effective March 23, 2021, John McMullen has resigned as a Director of the Company to focus on other business ventures.The Company wishes to thank John for his tremendous contribution and services as a director to Datametrex and wishes him all the best in his future endeavour. About DatametrexDatametrex AI Limited is ...
Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to announce that Heath Canada ("HC") has approved the PCL Inc.'s ("PCL") COVID19 AG Rapid test kit ("PCL Antigen"), an antigen point-of-care rapid test device under the Interim Order ("IO") Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19. Datametrex made an application ...